Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
BillionToOne's tissue-free Northstar Response ctDNA assay demonstrated 94% directional concordance with a tumor-informed test in a peer-reviewed head-to-head study. The assay also matched clinical ground truth in all discordant cases.
A new peer-reviewed study comparing BillionToOne's Tissue-Free Northstar Response® assay to tumor-informed ctDNA testing found 94% concordance. In discordant cases, the clinical ground-truth supported Northstar Response®.